echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Drugs Articles > The survival of the fittest in the pharmaceutical machinery industry

    The survival of the fittest in the pharmaceutical machinery industry

    • Last Update: 2015-11-01
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    The survival of the fittest high-tech equipment in the pharmaceutical machinery industry is guided by "Zhejiang Miller clean equipment Co., Ltd mile@china-mile.com": in recent years, the gap between domestic pharmaceutical machinery equipment and foreign products has been significantly narrowed Great changes have taken place in the production concept of the enterprise, and it is gradually recognized that quality is produced rather than inspected Therefore, the current pharmaceutical machinery will consider the dynamic monitoring needs of pharmaceutical production, add warning signs and other human-oriented design to help pharmaceutical plants achieve the whole process control It is reported that domestic pharmaceutical enterprises have experienced two major upgrades One was completed in 2004, and the other was still in progress, which had a huge impact on the domestic pharmaceutical industry GMP in China was formally implemented in 1988, during which it was revised twice Up to 2004, domestic pharmaceutical enterprises at that time had completed upgrading According to industry insiders, * times of upgrading and transformation led to the exit of nearly 1000 domestic pharmaceutical enterprises, with the cost of transformation reaching hundreds of billion RMB A major blood exchange was carried out for the pharmaceutical equipment at that time, which greatly improved the production standards and levels of the domestic pharmaceutical industry According to experts, the depreciation period of pharmaceutical machinery equipment is generally 8-10 years, and the pharmaceutical machinery equipment of the last round of price increase transformation has basically entered the list of renewal and elimination When pharmaceutical enterprises update and select equipment, they will first consider those pharmaceutical machinery enterprises with high technology content and good credit Therefore, it will become the main competitive means for pharmaceutical machinery enterprises to improve the stability of scientific and technological content and product quality, develop products with independent intellectual property rights, and improve after-sales service In recent years, the share of imported equipment in China is on the decline, and the domestic equipment with continuously improved quality and higher cost performance has become, which has brought huge business opportunities to the domestic pharmaceutical machinery industry The elbow of U-type diaphragm valve is welded by automatic welding machine, which meets the GMP requirements of pharmaceutical industry The long pipe part can be inspected by endoscope to see if the weld is flat and if there is any weld beading!
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.